Presentation is loading. Please wait.

Presentation is loading. Please wait.

FSCCD40 mediumFluCL097 25 %82 %97 % SSC FSC GEN2.2 cells B mediumFluCL097CpG ACpG B 0 20 40 60 80 100 GEN2.2 GENshTLR7 % CD40 positive cells TLR7TLR9 0.0.

Published byJasmin Daniel Modified over 9 years ago

Similar presentations

Presentation on theme: "FSCCD40 mediumFluCL097 25 %82 %97 % SSC FSC GEN2.2 cells B mediumFluCL097CpG ACpG B 0 20 40 60 80 100 GEN2.2 GENshTLR7 % CD40 positive cells TLR7TLR9 0.0."— Presentation transcript:

1 FSCCD40 mediumFluCL097 25 %82 %97 % SSC FSC GEN2.2 cells B mediumFluCL097CpG ACpG B 0 20 40 60 80 100 GEN2.2 GENshTLR7 % CD40 positive cells TLR7TLR9 0.0 0.5 1.0 1.5 2.0 2.5 GEN2.2 GENshTLR7 relative Ct A CD Figure 1 95 %85 % FluCL097pDC CD40 medium CD123 FSC 20 % BDCA2

2 A C B mediumFluCL097 0 2000 4000 6000 8000 10000 IFN α IL-6 IL-8 TNFα pg/ml medium Flu IFN  0.2 %56 % CL097 7 % BDCA-4 Figure 2 DE mediumFluCL097

3 Figure 3 AB CD 0.5h2h4h24h 0 2000 4000 6000 8000 10000 medium Flu CL097 IFN α (pg/ml) EF

4 Figure 4 AB mediumFluCL097 IFN α 0 20 40 60 80 100 well transwell % TRAIL positive cells C mediumFluCL097 IFN α 0 20 40 60 80 100 well well + anti-IFNα/β transwell transwell + anti-IFNα/β % TRAIL positive cells D

5 Figure 5 A B C medium FluCL097IFN  p-STAT1 p-STAT2 actin 0.5h 2h 0.5h 2h 0.5h 2h 0.5h 2h phospho-STAT1 FSC medium Flu CL097 IFN  5 % 30 % 29 % 65 % D medium FluCL097 IFN 

6 Figure 6 AB CD medium FluCL097 IFN  E mediumFluCL097 IFN  0 2000 4000 6000 8000 medium LY SB CXCL10 (pg/ml) F medium Flu SSC CL097 2 % TRAIL IFN  4 % 1 %3 %85 % 94 % 92 % medium SB LY 7 %10 % 90 %

Download ppt "FSCCD40 mediumFluCL097 25 %82 %97 % SSC FSC GEN2.2 cells B mediumFluCL097CpG ACpG B 0 20 40 60 80 100 GEN2.2 GENshTLR7 % CD40 positive cells TLR7TLR9 0.0."

Similar presentations

A. a). d). c). f). b).e). g). Figure S1. NAT2 expression in lymphocytes and monocytes from a healthy volunteer. PBMC from a healthy volunteer were simple.

A. a). d). c). f). b).e). g). Figure S1. NAT2 expression in lymphocytes and monocytes from a healthy volunteer. PBMC from a healthy volunteer were simple.
Counts TLR3-PE 100 80 60 40 20 0 Counts TLR8-PE 100 80 60 40 20 0 Counts TLR9-PE 100 80 60 40 20 0 C AB Supplemental Figure 1.

Counts TLR3-PE Counts TLR8-PE Counts TLR9-PE C AB Supplemental Figure 1.
A B Q Chord AB is 18. The radius of Circle Q is 15. How far is chord AB from the center of the circle? 9 15 (family!) 12 x.

A B Q Chord AB is 18. The radius of Circle Q is 15. How far is chord AB from the center of the circle? 9 15 (family!) 12 x.
Figure S1 a. Neutrophilsb. Non-inflammatory monocytes c. Macrophages or DCs d. Inflammatory monocytes SSC FSC B C SSC * * * * * III Count F4/80 A.

Figure S1 a. Neutrophilsb. Non-inflammatory monocytes c. Macrophages or DCs d. Inflammatory monocytes SSC FSC B C SSC * * * * * III Count F4/80 A.
Apaf-1 Caspase-9 Cyt c control sulindac control E LY294002 control TRAIL thapsigargin HT-29Chondrocyte control SIN-1 RAW 264.7 IP: AChE C Supplementary.

Apaf-1 Caspase-9 Cyt c control sulindac control E LY control TRAIL thapsigargin HT-29Chondrocyte control SIN-1 RAW IP: AChE C Supplementary.
CD68 NE-SSE NE-NS Figure E1. Nrf2 42-kD  actin 32-kD HO-1 100-kD Control si RNA si RNA Nrf2 Control si RNA si RNA Nrf2 Control si RNA si RNA Nrf2 Control.

CD68 NE-SSE NE-NS Figure E1. Nrf2 42-kD  actin 32-kD HO kD Control si RNA si RNA Nrf2 Control si RNA si RNA Nrf2 Control si RNA si RNA Nrf2 Control.
AB 11 22 33 44 55 66 77 88 99 10  20  19  18  17  16  15  14  13  12  11  21  22  23  24  25  26  27  28.

AB 11 22 33 44 55 66 77 88 99 10  20  19  18  17  16  15  14  13  12  11  21  22  23  24  25  26  27  28.
1/03/09 De 89 à 98. 1/03/09 De 89 à 98 1/03/09 De 89 à 98.

1/03/09 De 89 à 98. 1/03/09 De 89 à 98 1/03/09 De 89 à 98.
Fig. 16-CO, p. 449. Fig. 16-1, p. 450 Fig. 16-2, p. 450.

Fig. 16-CO, p Fig. 16-1, p. 450 Fig. 16-2, p. 450.
Clancy-Thompson et al., Supplemental Figure 1 A B C Supplemental Figure 1: Mice were given intravenous B16 injection on day 0. A) After bearing tumors.

Clancy-Thompson et al., Supplemental Figure 1 A B C Supplemental Figure 1: Mice were given intravenous B16 injection on day 0. A) After bearing tumors.
P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.

P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.
Host Defense Clinical and Experimental Immunologic Assays II Domenick Kennedy Dept. Microbiology and Immunology

Host Defense Clinical and Experimental Immunologic Assays II Domenick Kennedy Dept. Microbiology and Immunology
SUPPLEMENTAL MATERIAL AND METHOD Ag-presenting CpG-activated pDCs prime Th17 cells that induce tumor regression Leslie Guéry, Juan Dubrot, Carla Lippens,

SUPPLEMENTAL MATERIAL AND METHOD Ag-presenting CpG-activated pDCs prime Th17 cells that induce tumor regression Leslie Guéry, Juan Dubrot, Carla Lippens,
$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.
Find the geometric mean between: 1.4 and 9 2.3 and 6 3.6 and 20 4.15 and 20 Geometric Mean x is the geometric mean between a and b. a x x b = Similarity.

Find the geometric mean between: 1.4 and and and and 20 Geometric Mean x is the geometric mean between a and b. a x x b = Similarity.
V43 DNA-Ad26-ALVAC Study ELISpot SFC/Million PBMC.

V43 DNA-Ad26-ALVAC Study ELISpot SFC/Million PBMC.
Similar Figures Notes. Solving Proportions Review  Before we can discuss Similar Figures we need to review how to solve proportions…. Any ideas?

Similar Figures Notes. Solving Proportions Review  Before we can discuss Similar Figures we need to review how to solve proportions…. Any ideas?
Figure 1. Figure 2 ab p=0.0009 p=0.0014 *** Figure 3 a *** b cFos TP53 Beta actin cFos TP53 Beta actin.

Figure 1. Figure 2 ab p= p= *** Figure 3 a *** b cFos TP53 Beta actin cFos TP53 Beta actin.
Figure S1 (A) Analysis of purified myeloid DCs and T cells. Freshly isolated mDCs were processed for cytospins (A), stained with haematoxylin-eosin (x400.

Figure S1 (A) Analysis of purified myeloid DCs and T cells. Freshly isolated mDCs were processed for cytospins (A), stained with haematoxylin-eosin (x400.
 If three sides of one triangle are congruent to the three sides of another triangle, then the two triangles are congruent.  If AB = DE, BC = EF, AC.

 If three sides of one triangle are congruent to the three sides of another triangle, then the two triangles are congruent.  If AB = DE, BC = EF, AC.

Similar presentations

Ads by Google